- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.09. | Bone Biologics Corp - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 04.09. | Bone Biologics Shares Surges 37% After CEO Letter To Shareholders | 1 | RTTNews | ||
| 04.09. | Bone Biologics Corp - 8-K, Current Report | 4 | SEC Filings | ||
| 27.06. | Bone Biologics Prices $5 Mln Public Offering With Warrants At $4 Per Share | 1 | RTTNews | ||
| BONE BIOLOGICS Aktie jetzt für 0€ handeln | |||||
| 27.06. | Why Is Bone Biologics Stock Surging On Friday? | 4 | Benzinga.com | ||
| 27.06. | Bone Biologics prices $5M public offering with warrants; shares up 45% | 1 | Seeking Alpha | ||
| 27.06. | Why Bone Biologics Is Rising In Pre-market? | 2 | RTTNews | ||
| 26.06. | Bone Biologics Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 26.06. | Bone Biologics regains Nasdaq compliance with minimum bid price rule; shares down | 1 | Seeking Alpha | ||
| 24.06. | Bone Biologics files $35M mixed shelf offering | 7 | Seeking Alpha | ||
| 24.06. | Bone Biologics Corp - S-1, General form for registration of securities | 2 | SEC Filings | ||
| 06.06. | Bone Biologics plunges after announcing 1-for-6 reverse stock split | 2 | Seeking Alpha | ||
| 06.06. | Bone Biologics kündigt Aktienzusammenlegung im Verhältnis 1:6 an | 2 | Investing.com Deutsch | ||
| 06.06. | Bone Biologics announces 1-for-6 reverse stock split | 1 | Investing.com | ||
| 06.06. | Bone Biologics Corporation Announces 1-for-6 Reverse Stock Split | 978 | Business Wire | TYSONS CORNER, Va.--(BUSINESS WIRE)--Strategy (Nasdaq: MSTR/STRK/STRF) today announced the pricing of its initial public offering on June 5, 2025 of 11,764,700 shares of 10.00% Series A Perpetual Stride... ► Artikel lesen | |
| 30.05. | Aktionäre von Bone Biologics genehmigen wichtige Vorschläge | - | Investing.com Deutsch | ||
| 30.05. | Bone Biologics Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 12.05. | Bone Biologics Corp - 10-Q, Quarterly Report | 2 | SEC Filings |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,115 | +5,50 % | Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - October 1, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTCQB: SEOVF) (FSE: PSH0) ("Sernova") a leading regenerative medicine company focused... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,850 | +8,14 % | Atossa Therapeutics appoints Janet Rea as SVP of R&D | ||
| PING AN HEALTHCARE | 2,004 | -2,72 % | Ping An Healthcare and Technology Company Limited: Ping An Good Doctor (1833.HK) Reports Solid Interim Results with Steady Revenue and Profit Growth | HONG KONG, Aug. 20, 2025 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited (the "Company"; Stock Code: 1833.HK) announced its interim results for the six months ended June... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,011 | -13,85 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
| CO-DIAGNOSTICS | 0,290 | -6,45 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
| VERU | 3,825 | 0,00 % | These small cap stocks are poised for a comeback - Palisade Capital's Dan Veru | ||
| CYTOSORBENTS | 0,812 | +2,65 % | CytoSorbents Corporation: CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR | FDA appeal decision found no issues with DrugSorb-ATR device safety but upheld the De Novo denial, and proposes a potential path forward for market authorization... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update | Received clearance to proceed with pivotal trial of amezalpat combination therapy for first-line hepatocellular carcinoma (HCC) in ChinaGranted orphan drug designation from the European Medicines... ► Artikel lesen | |
| VOLITIONRX | 0,635 | 0,00 % | H.C. Wainwright reiterates buy rating on VolitionRX stock at $2.50 | ||
| EKSO BIONICS | 5,680 | +7,58 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
| IMUNON | 4,440 | -3,90 % | Imunon, Inc.: IMUNON Successfully Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement | LAWRENCEVILLE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that the Company... ► Artikel lesen | |
| BEYOND AIR | 2,480 | -0,40 % | Beyond Air Signs New International LungFit PH Distribution Agreements, Most Notably in Japan | GARDEN CITY, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial-stage medical device and biopharmaceutical company focused on harnessing... ► Artikel lesen | |
| AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| NOVACYT | 0,480 | -0,93 % | Novacyt S.A. - Liquidity Agreement Monthly Update and TVR | ||
| AROVELLA THERAPEUTICS | 0,052 | 0,00 % | Arovella Therapeutics' CAR-T Cells Show Promise in Eliminating Pancreatic Cancer Cells |
Das Unternehmen BONE BIOLOGICS CORP kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 2,550 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BONE BIOLOGICS CORP finden Sie auf Wallstreet Online.